Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

UroGen Pharma (URGN) Inventory Average (2017 - 2025)

UroGen Pharma (URGN) has disclosed Inventory Average for 7 consecutive years, with $12.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Inventory Average rose 47.46% year-over-year to $12.4 million, compared with a TTM value of $12.4 million through Dec 2025, up 47.46%, and an annual FY2025 reading of $12.8 million, up 72.42% over the prior year.
  • Inventory Average was $12.4 million for Q4 2025 at UroGen Pharma, up from $7.7 million in the prior quarter.
  • Across five years, Inventory Average topped out at $12.4 million in Q4 2025 and bottomed at $2.6 million in Q1 2021.
  • Average Inventory Average over 5 years is $6.0 million, with a median of $5.1 million recorded in 2023.
  • The sharpest move saw Inventory Average surged 192.55% in 2021, then increased 0.22% in 2025.
  • Year by year, Inventory Average stood at $4.3 million in 2021, then grew by 6.33% to $4.6 million in 2022, then increased by 16.2% to $5.3 million in 2023, then skyrocketed by 57.57% to $8.4 million in 2024, then surged by 47.46% to $12.4 million in 2025.
  • Business Quant data shows Inventory Average for URGN at $12.4 million in Q4 2025, $7.7 million in Q3 2025, and $7.4 million in Q2 2025.